Is α-Actinin A Target for Pathogenic Anti-DNA Antibodies in Lupus Nephritis?

Lesley J. Mason, Chelliah T. Ravirajan, Anisur Rahman, Chaim Putterman, David A. Isenberg

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Objective. Following recent reports that pathogenic murine anti-DNA antibodies bind to α-actinin, it was obviously of interest to assess the ability of human pathogenic anti-double-stranded DNA (anti-dsDNA) antibodies to bind this antigen. Both human monoclonal anti-DNA antibodies and antibodies affinity purified from the sera of patients with systemic lupus erythematosus (SLE) were investigated. Methods. An enzyme-linked immunosorbent assay was established to measure immunoglobulin binding to α-actinin. Antibodies binding dsDNA were purified from the sera of SLE patients who either had active renal disease or had never had renal disease. Serum samples were selected at times when the patients' sera exhibited high IgG binding to dsDNA. The binding of supernatants from 3 high-affinity human anti-dsDNA IgG hybridomas (RH14, B3, and DIL-6) and 7 human IgM anti-DNA hybridomas was also investigated. Results. A greater proportion of anti-dsDNA IgG-binding antibodies purified from patients with renal disease bound to α-actinin than did those purified from the sera of patients without renal disease. The specificity of binding to the 100-kd α-actinin molecule was confirmed by Western blotting. The pathogenic human antibodies RH14 and B3 bound strongly to α-actinin, while nonpathogenic DIL-6 bound very weaky. RT84, the IgM antibody that binds dsDNA with the highest affinity, exhibited the greatest binding to α-actinin. Conclusion. The results of our study support the findings of previous studies using murine anti-DNA monoclonal antibodies, which suggest that pathogenic anti-dsDNA antibodies cross-react with α-actinin.

Original languageEnglish (US)
Pages (from-to)866-870
Number of pages5
JournalArthritis and Rheumatism
Volume50
Issue number3
DOIs
StatePublished - Mar 2004

Fingerprint

Actinin
Lupus Nephritis
Anti-Idiotypic Antibodies
Antibodies
Kidney
Serum
Immunoglobulin G
Hybridomas
Systemic Lupus Erythematosus
DNA
Antibody Affinity
Immunoglobulin M
Immunoglobulins
Western Blotting
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Antigens

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Is α-Actinin A Target for Pathogenic Anti-DNA Antibodies in Lupus Nephritis? / Mason, Lesley J.; Ravirajan, Chelliah T.; Rahman, Anisur; Putterman, Chaim; Isenberg, David A.

In: Arthritis and Rheumatism, Vol. 50, No. 3, 03.2004, p. 866-870.

Research output: Contribution to journalArticle

Mason, Lesley J. ; Ravirajan, Chelliah T. ; Rahman, Anisur ; Putterman, Chaim ; Isenberg, David A. / Is α-Actinin A Target for Pathogenic Anti-DNA Antibodies in Lupus Nephritis?. In: Arthritis and Rheumatism. 2004 ; Vol. 50, No. 3. pp. 866-870.
@article{5c475bf25579471889957f9b2fa66334,
title = "Is α-Actinin A Target for Pathogenic Anti-DNA Antibodies in Lupus Nephritis?",
abstract = "Objective. Following recent reports that pathogenic murine anti-DNA antibodies bind to α-actinin, it was obviously of interest to assess the ability of human pathogenic anti-double-stranded DNA (anti-dsDNA) antibodies to bind this antigen. Both human monoclonal anti-DNA antibodies and antibodies affinity purified from the sera of patients with systemic lupus erythematosus (SLE) were investigated. Methods. An enzyme-linked immunosorbent assay was established to measure immunoglobulin binding to α-actinin. Antibodies binding dsDNA were purified from the sera of SLE patients who either had active renal disease or had never had renal disease. Serum samples were selected at times when the patients' sera exhibited high IgG binding to dsDNA. The binding of supernatants from 3 high-affinity human anti-dsDNA IgG hybridomas (RH14, B3, and DIL-6) and 7 human IgM anti-DNA hybridomas was also investigated. Results. A greater proportion of anti-dsDNA IgG-binding antibodies purified from patients with renal disease bound to α-actinin than did those purified from the sera of patients without renal disease. The specificity of binding to the 100-kd α-actinin molecule was confirmed by Western blotting. The pathogenic human antibodies RH14 and B3 bound strongly to α-actinin, while nonpathogenic DIL-6 bound very weaky. RT84, the IgM antibody that binds dsDNA with the highest affinity, exhibited the greatest binding to α-actinin. Conclusion. The results of our study support the findings of previous studies using murine anti-DNA monoclonal antibodies, which suggest that pathogenic anti-dsDNA antibodies cross-react with α-actinin.",
author = "Mason, {Lesley J.} and Ravirajan, {Chelliah T.} and Anisur Rahman and Chaim Putterman and Isenberg, {David A.}",
year = "2004",
month = "3",
doi = "10.1002/art.20103",
language = "English (US)",
volume = "50",
pages = "866--870",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Is α-Actinin A Target for Pathogenic Anti-DNA Antibodies in Lupus Nephritis?

AU - Mason, Lesley J.

AU - Ravirajan, Chelliah T.

AU - Rahman, Anisur

AU - Putterman, Chaim

AU - Isenberg, David A.

PY - 2004/3

Y1 - 2004/3

N2 - Objective. Following recent reports that pathogenic murine anti-DNA antibodies bind to α-actinin, it was obviously of interest to assess the ability of human pathogenic anti-double-stranded DNA (anti-dsDNA) antibodies to bind this antigen. Both human monoclonal anti-DNA antibodies and antibodies affinity purified from the sera of patients with systemic lupus erythematosus (SLE) were investigated. Methods. An enzyme-linked immunosorbent assay was established to measure immunoglobulin binding to α-actinin. Antibodies binding dsDNA were purified from the sera of SLE patients who either had active renal disease or had never had renal disease. Serum samples were selected at times when the patients' sera exhibited high IgG binding to dsDNA. The binding of supernatants from 3 high-affinity human anti-dsDNA IgG hybridomas (RH14, B3, and DIL-6) and 7 human IgM anti-DNA hybridomas was also investigated. Results. A greater proportion of anti-dsDNA IgG-binding antibodies purified from patients with renal disease bound to α-actinin than did those purified from the sera of patients without renal disease. The specificity of binding to the 100-kd α-actinin molecule was confirmed by Western blotting. The pathogenic human antibodies RH14 and B3 bound strongly to α-actinin, while nonpathogenic DIL-6 bound very weaky. RT84, the IgM antibody that binds dsDNA with the highest affinity, exhibited the greatest binding to α-actinin. Conclusion. The results of our study support the findings of previous studies using murine anti-DNA monoclonal antibodies, which suggest that pathogenic anti-dsDNA antibodies cross-react with α-actinin.

AB - Objective. Following recent reports that pathogenic murine anti-DNA antibodies bind to α-actinin, it was obviously of interest to assess the ability of human pathogenic anti-double-stranded DNA (anti-dsDNA) antibodies to bind this antigen. Both human monoclonal anti-DNA antibodies and antibodies affinity purified from the sera of patients with systemic lupus erythematosus (SLE) were investigated. Methods. An enzyme-linked immunosorbent assay was established to measure immunoglobulin binding to α-actinin. Antibodies binding dsDNA were purified from the sera of SLE patients who either had active renal disease or had never had renal disease. Serum samples were selected at times when the patients' sera exhibited high IgG binding to dsDNA. The binding of supernatants from 3 high-affinity human anti-dsDNA IgG hybridomas (RH14, B3, and DIL-6) and 7 human IgM anti-DNA hybridomas was also investigated. Results. A greater proportion of anti-dsDNA IgG-binding antibodies purified from patients with renal disease bound to α-actinin than did those purified from the sera of patients without renal disease. The specificity of binding to the 100-kd α-actinin molecule was confirmed by Western blotting. The pathogenic human antibodies RH14 and B3 bound strongly to α-actinin, while nonpathogenic DIL-6 bound very weaky. RT84, the IgM antibody that binds dsDNA with the highest affinity, exhibited the greatest binding to α-actinin. Conclusion. The results of our study support the findings of previous studies using murine anti-DNA monoclonal antibodies, which suggest that pathogenic anti-dsDNA antibodies cross-react with α-actinin.

UR - http://www.scopus.com/inward/record.url?scp=1542283744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542283744&partnerID=8YFLogxK

U2 - 10.1002/art.20103

DO - 10.1002/art.20103

M3 - Article

C2 - 15022329

AN - SCOPUS:1542283744

VL - 50

SP - 866

EP - 870

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 3

ER -